Amin Virani, PharmD, is a highly experienced pharmaceutical professional specializing in oncology. Currently serving as the Scientific Director for Oncology in US Medical Affairs at AbbVie since May 2023, Amin Virani has been instrumental in developing the medical strategy for the pre-launch and launch of Telisotuzumab vedotin and its companion diagnostic in c-Met overexpressed NSCLC. Previous roles include Associate Scientific Director and Assistant Scientific Director at AbbVie, where leadership in evidence generation and trial acceleration was achieved. Prior to AbbVie, Amin Virani worked as a Medical Science Liaison at Sanofi, supporting the launch of Isatuximab, and as a Clinical Pharmacy Manager at NewYork-Presbyterian Hospital, where pharmacy services in oncology were led. Amin Virani completed PGY1 and PGY2 residencies at UChicago Medicine, focusing on oncology, after earning a Doctor of Pharmacy from the University of Illinois Chicago and a Bachelor of Science in Molecular & Cellular Biology from the University of Illinois Urbana-Champaign.
This person is not in the org chart
This person is not in any teams
This person is not in any offices